Ad
related to: aerotek pharmaceutical solutions llc
Search results
Results From The WOW.Com Content Network
Founded as Aerotek in 1983 by Jim C. Davis and Steve Bisciotti, the company originally focused on the engineering and aerospace industry. [3] Bisciotti would go on to become owner of the Baltimore Ravens. [1] [4] As of January 2023, Jay Alvather serves as the Allegis Group CEO. [5] Allegis Group's subsidiaries include: [1] Aerotek
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.
As Americans are increasingly reaching for pharmaceutical solutions for depression—about one in eight U.S. adults takes antidepressants—scientists have been innovating novel treatments for it.
Baxter sold its BioPharma Solutions business in October for $4.25 billion to investment firms. The new company, Simtra, wants to expand. Monroe County pharmaceutical company Baxter is now Simtra ...
Aptalis was a company in the pharmaceutical industry.In January 2014, the company was acquired by Forest Laboratories (acquired by Allergan) for $675 million.Through a series of acquisitions, the company is now a contract development and manufacturing organization and rebranded as Adare Phama Solutions, headquartered in Lawrenceville, New Jersey.
Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets ...
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina , the company specializes in helping other companies with late-stage clinical trials, but also provides ...
MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca. [1] [2] MedImmune was founded in 1988 as Molecular Vaccines, Inc, and was purchased in 2007 for $15.6 billion. [3]